img 614-636-4850
  • Follow us:

Biosortia Pharmaceuticals is the only company in the world directly accessing the aquatic microbiome for metabolite and elicited secondary metabolite chemistry from unculturable and culturable microorganisms. Biosortia typically samples and processes >20,000,000 liters of dilute microbial consortia (.02g/l) with no environmental impact. These proprietary technologies and processes permit direct chemical access of highly refined mixtures of chemistry for the screening of high priority unmet needs in key therapeutic areas. Biosortia has proven access and continued accessibility to previously unobtainable active, potent and novel chemistry, virtually eliminating key historical hurdle issues with aquatic drug discovery.